Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Racing body advises against injectable Omeprazole
Samples of the injectable Omeprazole 100mg/ml (BOVA UK) were found to contain low levels of testosterone.

Product found to contain low levels of testosterone

Injectable Omeprazole should not be used in racehorses due to the presence of testosterone, the British Horseracing Authority (BHA) has advised.

BHA encouraged trainers to discuss alternative treatments with their veterinary surgeons.

Analytical laboratory LGC looked at a number of products containing Omeprazole. Samples of the injectable Omeprazole 100mg/ml (BOVA UK) were found to contain low levels of testosterone.

No oral preparations were found to contain testosterone or any other anabolic steroid.

BHA warned that the possession, use or attempted use of this product could amount to a breach of the Rules of Racing.

Presence of testosterone over the permitted threshold in a sample could result in a 14-month suspension from racing and a 12-month stand down from racing for the horse, as well as other penalties for the Responsible Person.

Trainers and other industry participants were advised to remove the product from all licensed premises and not to administer the product to a thoroughbred from birth until permanent retirement from racing. 

Become a member or log in to add this story to your CPD history

Regional Representatives nominations sought

News Story 1
 Seven new regional representatives are being sought by the British Veterinary Association (BVA) to speak for vets from those regions and to represent their views to BVA Council.

The opportunities are available in in the North-East, Yorkshire & Humber, East Midlands, West Midlands, London, Wales, and Northern Ireland. Representatives from all sectors of the veterinary profession are urged to apply.

BVA president Daniella Dos Santos, said: "Our regional representatives are integral to that mission and to the activities of Council - contributing to effective horizon scanning on matters of veterinary policy and providing an informed steer to BVA’s Policy Committee.” 

Click here for more...
News Shorts
Livestock Antibody Hub receives funding boost

The Pirbright Institute has received US $5.5 million from the Bill and Melinda Gates Foundation to form a Livestock Antibody Hub aimed at supporting animal and human health. The work will bring together researchers from across the UK utilise research outcomes in livestock disease and immunology.

Dr Doug Brown, chief executive of the British Society for Immunology, commented: “The UK is a world leader in veterinary immunology research, and this transformative investment from the Bill & Melinda Gates Foundation will drive the next chapter of innovation in developing new treatments and prevention options against livestock diseases".